Effect of survivin on cell proliferation and apoptosis in gastric cancer. 2002

Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
Department of Surgery, Tokyo Medical University, Shinjuku-ku, Tokyo 160-0023, Japan. ywakana@a2.mbn.or.jp

We investigated the effect of expression of survivin, an apoptosis inhibiting protein, on cellular proliferation and apoptosis in gastric cancer and assessed its relation to the pathological characteristics of gastric cancer. Resected gastric cancer specimens from 42 patients (intestinal type; 21 cases and diffuse type; 21 cases) were evaluated. There were no significant differences in the clinicopathologic factors between the two groups. Survivin mRNA expression was measured using real-time reverse transcription-polymerase chain reaction, and survivin protein expression was evaluated by immunohistochemical staining. The Ki-67 index was adopted for cell proliferation scoring, and the ss-DNA positive rate as an apoptotic index. The survivin mRNA expression inversely correlated with the apoptotic index (p<0.05). Survivin mRNA expression (p<0.001) and survivin protein expression (p<0.001) were significantly higher in the diffuse type than the intestinal type. In conclusion, gastric cancer avoids cellular death by survivin expression and this tendency was more conspicuous in diffuse type gastric cancer.

UI MeSH Term Description Entries
D007124 Immunoenzyme Techniques Immunologic techniques based on the use of: (1) enzyme-antibody conjugates; (2) enzyme-antigen conjugates; (3) antienzyme antibody followed by its homologous enzyme; or (4) enzyme-antienzyme complexes. These are used histologically for visualizing or labeling tissue specimens. Antibody Enzyme Technique, Unlabeled,Enzyme Immunoassay,Enzyme-Labeled Antibody Technique,Immunoassay, Enzyme,Immunoperoxidase Techniques,Peroxidase-Antiperoxidase Complex Technique,Peroxidase-Labeled Antibody Technique,Antibody Enzyme Technic, Unlabeled,Enzyme-Labeled Antibody Technic,Immunoenzyme Technics,Immunoperoxidase Technics,Peroxidase-Antiperoxidase Complex Technic,Peroxidase-Labeled Antibody Technic,Antibody Technic, Enzyme-Labeled,Antibody Technic, Peroxidase-Labeled,Antibody Technics, Enzyme-Labeled,Antibody Technics, Peroxidase-Labeled,Antibody Technique, Enzyme-Labeled,Antibody Technique, Peroxidase-Labeled,Antibody Techniques, Enzyme-Labeled,Antibody Techniques, Peroxidase-Labeled,Enzyme Immunoassays,Enzyme Labeled Antibody Technic,Enzyme Labeled Antibody Technique,Enzyme-Labeled Antibody Technics,Enzyme-Labeled Antibody Techniques,Immunoassays, Enzyme,Immunoenzyme Technic,Immunoenzyme Technique,Immunoperoxidase Technic,Immunoperoxidase Technique,Peroxidase Antiperoxidase Complex Technic,Peroxidase Antiperoxidase Complex Technique,Peroxidase Labeled Antibody Technic,Peroxidase Labeled Antibody Technique,Peroxidase-Antiperoxidase Complex Technics,Peroxidase-Antiperoxidase Complex Techniques,Peroxidase-Labeled Antibody Technics,Peroxidase-Labeled Antibody Techniques,Technic, Enzyme-Labeled Antibody,Technic, Immunoenzyme,Technic, Immunoperoxidase,Technic, Peroxidase-Antiperoxidase Complex,Technic, Peroxidase-Labeled Antibody,Technics, Enzyme-Labeled Antibody,Technics, Immunoenzyme,Technics, Immunoperoxidase,Technics, Peroxidase-Antiperoxidase Complex,Technics, Peroxidase-Labeled Antibody,Technique, Enzyme-Labeled Antibody,Technique, Immunoenzyme,Technique, Immunoperoxidase,Technique, Peroxidase-Antiperoxidase Complex,Technique, Peroxidase-Labeled Antibody,Techniques, Enzyme-Labeled Antibody,Techniques, Immunoenzyme,Techniques, Immunoperoxidase,Techniques, Peroxidase-Antiperoxidase Complex,Techniques, Peroxidase-Labeled Antibody
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008869 Microtubule-Associated Proteins High molecular weight proteins found in the MICROTUBULES of the cytoskeletal system. Under certain conditions they are required for TUBULIN assembly into the microtubules and stabilize the assembled microtubules. Ensconsin,Epithelial MAP, 115 kDa,Epithelial Microtubule-Associate Protein, 115 kDa,MAP4,Microtubule Associated Protein,Microtubule Associated Protein 4,Microtubule Associated Protein 7,Microtubule-Associated Protein,Microtubule-Associated Protein 7,E-MAP-115,MAP1 Microtubule-Associated Protein,MAP2 Microtubule-Associated Protein,MAP3 Microtubule-Associated Protein,Microtubule Associated Proteins,Microtubule-Associated Protein 1,Microtubule-Associated Protein 2,Microtubule-Associated Protein 3,7, Microtubule-Associated Protein,Associated Protein, Microtubule,E MAP 115,Epithelial Microtubule Associate Protein, 115 kDa,MAP1 Microtubule Associated Protein,MAP2 Microtubule Associated Protein,MAP3 Microtubule Associated Protein,Microtubule Associated Protein 1,Microtubule Associated Protein 2,Microtubule Associated Protein 3,Microtubule-Associated Protein, MAP1,Microtubule-Associated Protein, MAP2,Microtubule-Associated Protein, MAP3,Protein 7, Microtubule-Associated,Protein, Microtubule Associated,Protein, Microtubule-Associated
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009361 Neoplasm Invasiveness Ability of neoplasms to infiltrate and actively destroy surrounding tissue. Invasiveness, Neoplasm,Neoplasm Invasion,Invasion, Neoplasm
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D004277 DNA, Single-Stranded A single chain of deoxyribonucleotides that occurs in some bacteria and viruses. It usually exists as a covalently closed circle. Single-Stranded DNA,DNA, Single Stranded,Single Stranded DNA

Related Publications

Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
November 2004, Zhonghua yi xue za zhi,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
January 2015, International journal of clinical and experimental pathology,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
February 2014, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
August 2009, Journal of digestive diseases,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
November 1999, Laboratory investigation; a journal of technical methods and pathology,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
March 2014, European journal of cell biology,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
January 2014, Journal of B.U.ON. : official journal of the Balkan Union of Oncology,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
March 2010, Chinese journal of cancer,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
August 2006, Cancer,
Yoichi Wakana, and Kazuhiko Kasuya, and Soh Katayanagi, and Akihiko Tsuchida, and Tatsuya Aoki, and Yasuhisa Koyanagi, and Hideaki Ishii, and Yoshiro Ebihara
June 2006, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi,
Copied contents to your clipboard!